Literature DB >> 8116750

Experimental transplantation of human retinal pigment epithelial cells on collagen substrates.

N S Bhatt1, D A Newsome, T Fenech, T P Hessburg, J G Diamond, M V Miceli, K E Kratz, P D Oliver.   

Abstract

We studied the use of human retinal pigment epithelial cells cultured on a collagen support as a potential transplantation therapy to replace diseased or damaged retinal pigment epithelium. Using a transvitreal approach, we transplanted human retinal pigment epithelial cells attached to either a sheet of noncross-linked or cross-linked type I collagen into the subretinal space of New Zealand white rabbits, whose eyes lack pigment. Animals were killed after six weeks, and the eyes were fixed for light microscopy. The results demonstrated that, in eyes receiving the noncross-linked collagen support, a layer of pigmented donor retinal pigment epithelium was visible within the subretinal space, with a normal-appearing retina and no evidence of proliferative vitreoretinopathy or graft rejection. We believe this method may be applicable to replace dysfunctional retinal pigment epithelial cells in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8116750     DOI: 10.1016/s0002-9394(14)73079-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  20 in total

Review 1.  Basement membranes and artificial substrates in cell transplantation.

Authors:  Carl Sheridan; Rachel Williams; Ian Grierson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-20       Impact factor: 3.117

Review 2.  A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space.

Authors:  Sara Royce Hynes; Erin B Lavik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-19       Impact factor: 3.117

Review 3.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

4.  Transplanted and repopulated retinal pigment epithelial cells on damaged Bruch's membrane in rabbits.

Authors:  C Shiragami; T Matsuo; F Shiraga; N Matsuo
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

5.  Utilizing Recombinant Spider Silk Proteins To Develop a Synthetic Bruch's Membrane for Modeling the Retinal Pigment Epithelium.

Authors:  Thomas I Harris; Chase A Paterson; Farhad Farjood; Ian D Wadsworth; Lori Caldwell; Randolph V Lewis; Justin A Jones; Elizabeth Vargis
Journal:  ACS Biomater Sci Eng       Date:  2019-07-16

6.  Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue.

Authors:  Balendu Shekhar Jha; Kapil Bharti
Journal:  Curr Stem Cell Rep       Date:  2015-06

7.  Human iPSC-Derived Neural Progenitors Preserve Vision in an AMD-Like Model.

Authors:  Yuchun Tsai; Bin Lu; Benjamin Bakondi; Sergey Girman; Anais Sahabian; Dhruv Sareen; Clive N Svendsen; Shaomei Wang
Journal:  Stem Cells       Date:  2015-06-02       Impact factor: 6.277

Review 8.  Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.

Authors:  Melissa K Jones; Bin Lu; Sergey Girman; Shaomei Wang
Journal:  Prog Retin Eye Res       Date:  2017-01-19       Impact factor: 21.198

9.  Development of a surface to increase retinal pigment epithelial cell (ARPE-19) proliferation under reduced serum conditions.

Authors:  Agnieszka A Zuber; David E Robinson; Robert D Short; David A Steele; Jason D Whittle
Journal:  J Mater Sci Mater Med       Date:  2014-02-04       Impact factor: 3.896

Review 10.  Spheramine for treatment of Parkinson's disease.

Authors:  Natividad P Stover; Ray L Watts
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.